GLOBAL FOREX NEWS

View all

Jul22

How to Choose Between Market Execution and Instant Execution at EXNESS

How to Choose Between Market Execution and Instant Execution at EXNESS Last year EXNESS introduced Market Execution to its repertoire of trading orders, to diversify the trading experience and make it more profitable. Read more
Jul18

The Pitfalls of Overtrading by fxwire.com

The Pitfalls of Overtrading by fxwire.com Overtrading is one of the biggest forex trading pitfalls a trader can encounter and as such should be completely avoided to avoid draining your account. Read more
Jul17

Top Tips to Eliminate Forex Trading Emotion

Top Tips to Eliminate Forex Trading Emotion It’s essential that you learn to trade with zero emotion if you wish to make steady profits. Follow these 3 tips to eliminate emotion & make better profits. Read more
Jul16

3 Critical Steps Towards your Forex Trading Success

3 Critical Steps Towards your Forex Trading Success Forex trading is a combination of physical and mental preparation. Follow the 3 critical steps featured here to improve your chances of FX trading success. Read more
Jul15

The Advantages of EXNESS’ Unique Instant Withdrawal

The Advantages of EXNESS’ Unique Instant Withdrawal EXNESS’ instant withdrawal is convenient, fast and safe. Take advantage of EXNESS’ instant withdrawal feature to receive your funds immediately! Read more
Jul11

WTI Drops Following Libya’s Crude Output Levels Report Release

WTI Drops Following Libya’s Crude Output Levels Report Release Amid Libya boosting its output levels on crude oil, whilst at the same time stockpiles of gasoline in the U.S. expanded the most, West Texas Intermediate Read more

TOP REUTERS NEWS

View all

by Reuters Business News / 05.26.2014
LONDON/NEW YORK (Reuters) - Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the... Read more
by Reuters Business News / 05.21.2014
LONDON (Reuters) - Pfizer's chances of striking a deal to buy AstraZeneca in the coming days look vanishingly small, but the notion it could return later this year is propping up the British... Read more
by Reuters Business News / 05.20.2014
LONDON (Reuters) - Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, puncturing the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals... Read more
by Reuters Business News / 05.19.2014
LONDON (Reuters) - U.S. drugmaker Pfizer said on Sunday it had raised its offer for British rival AstraZeneca to 69.3 billion pounds ($116.6 billion), or 55 pounds a share, and would walk away if... Read more
by Reuters Business News / 05.14.2014
LONDON (Reuters) - Pfizer said it would ringfence the development of important drugs if it acquired AstraZeneca , rejecting a charge from the British company that a takeover would disrupt important... Read more
by Reuters Business News / 05.13.2014
LONDON (Reuters) - U.S. drugmaker Pfizer hinted it could raise its proposed $106 billion offer if AstraZeneca would only engage in talks, as its boss was grilled by UK lawmakers on his commitment to... Read more
by Reuters Business News / 05.12.2014
LONDON (Reuters) - Pfizer defended the business case behind its plan to acquire AstraZeneca on Monday and questioned the UK drugmaker's ability to stand alone for much longer as the New York-based... Read more
by Reuters Business News / 05.08.2014
(Reuters) - Wellcome Trust, Britain's biggest medical research foundation said it had "major concerns" about U.S. drug major Pfizer's 63 billion pound offer for AstraZeneca , the Financial Times... Read more

Technical Analysis

View all

Jul11

Bearish Pressures at 1.3607 on EUR/USD

Bearish Pressures at 1.3607 on EUR/USD EUR/USD has been lately stabilizing at 1.3607, slightly upper than key support zone 1.3575 and lower than key resistance level 1.3650. Read more
Jul11

Stability at 1.7131 on GBP/USD

Stability at 1.7131 on GBP/USD GBP/USD has been recently stabilizing at 1.7131 the key mid-point level for today’s trading session. Read more

Warning: Trading forex and CFDs on margin can result in the loss of your entire invested capital. Forex, CFDs and other instruments are not suitable for every person. You should only speculate with money you can afford to lose. Before trading you should fully understand the risks involved and take into consideration your level of experience.